Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.11
Delayed Data
As of Sep 02
 0.00 / 0.00%
Today’s Change
0.08
Today|||52-Week Range
0.80
-83.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.1K42.3K323.4K199.6K
 
 
 
 
 
Cost of Goods Sold6.4K56.9K211.1K104.9K
 
 
 
 
 
Depreciation And Amortization64.3K65.0K67.1K70.9K
 
 
 
 
 
 
Operating ExpensesGross Income-66.5K-79.6K45.2K23.8K
 
 
 
 
 
General Expenses745.0K1.4M4.6M4.7M
 
 
 
 
 
Research And Development130.0K114.0K542.5K1.4M
 
 
 
 
 
Total Operating Expenses815.6K1.5M4.9M4.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-811.5K-1.5M-4.6M-4.7M
 
 
 
 
 
Interest Expense On Debt15.7K18.4K19.7K20.0K
 
 
 
 
 
Other Expenses0.00-3.2K-1.6K-5.6K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-827.2K-1.5M-4.6M-4.7M
 
 
 
 
 
Net Income-827.2K-1.5M-4.6M-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.1M16.9M25.4M38.2M
 
 
 
 
 
Shares To Calculate EPS Diluted15.1M16.9M25.4M38.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.09-$0.18-$0.12
 
 
 
 
 
EPS Diluted-$0.05-$0.09-$0.18-$0.12